The novel therapy of this peptide represents a major development in the management of the condition. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide757805.dm-blog.com/42361559/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment